S.D.N.Y. · No. 1:26-cv-07077
Full docket on CourtListener ↗
No federal docket timeline hydrated for this case yet (state-court settlements have no RECAP docket).
| Matter | Type | Practice area | Court | Date | Value |
|---|---|---|---|---|---|
| Compass, Inc.source ↗ filed by Yagman PLLC · Judge Margaret M. Garnett · No. 1:26-cv-07077 · 15:15 Antitrust Litigation · view case timeline → Comparable settlements $7.85M–$34B ▾No rulings yet for this theory, but the NAR commission-fixing case ($120M settlement, N.D. Ill.) shows real-estate brokerage antitrust claims can survive and settle at scale. Compass, as a major residential brokerage, faces similar commission-structure exposure. Comparable settlements $7.85M–$34B median $128M · n=10 Visa and Mastercar $34B · Blue Cross Blue Sh $2.67B · Discover $1.23B Per member (realized): ~$10 median · $10–$10 (n=1) Comparable verdict: Chinese vitamin C ma $54.10M · Two Chinese vitamin $54.10M Key precedent: NAR settlement ($120M) — same industry, same commission-fixing theory, sets a template for scope and structure of relief. Main risk: Antitrust price-fixing claims require proving concerted action; absent a ruling, dismissal on Sherman Act pleading standards (as seen in many failed antitrust suits) is a real threat. Rough EV model (wide — class size is the big unknown, not a prediction): $1M–$60M Extremely thin data: no rulings for this theory, single-point per-member benchmark, and class size is inferred, not sourced from case filings. · grounded in 0 rulings, 10 settlements, 2 verdicts | Filing | Antitrust / Price-Fixing | S.D.N.Y. | 2026-08-19 | $7.85M–$34B comparable settlements |